DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "The U.S Clinical Chemistry Analyzers Market Research Report, By Type, By Test and By End Users - Market trends, Market Share, Industry Analysis and Forecast 2014-2021" report to their offering.
The U.S clinical chemistry analyzers market is segmented by type of devices and reagents and consumables, by test and by end users. The report includes estimation and forecast of the U.S. Clinical Chemistry Analyzers Market in terms of revenue (in USD million) for 2015 to 2021. The U.S. is the one of the largest markets of clinical chemistry analyzers. The market is dominated by reagents and consumables.
The major growth factors of the U.S. clinical chemistry analyzers market are: increasing medical insurance in the U.S., advances in point-of-care and combinatorial testing, increasing healthcare expenditure etc. Factors restraining the U.S. clinical chemistry analyzers market are: tough regulatory policies and initial high fixed cost.
The report includes in depth analysis of market drivers, restraints, market trends and competitive landscape. In the competitive landscape section it includes all market deals of last 3 years of the U.S. clinical chemistry analyzers market. It includes new product launches, mergers and acquisitions, joint ventures, agreements etc.
The market size is estimated and forecasted by utilizing fundamental inputs gathered from comprehensive data extraction of both free and paid sources which are further validated by primary interviews and various macro-economic factors which affect the market.
The major players operating in this market are
- Abbott Laboratories
- Beckman Coulter (Subsidiary of Danaher Corporation)
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson Inc
- Thermo Fisher Scientific Inc.
For more information about this report visit http://www.researchandmarkets.com/research/g9cjpk/the_u_s_clinical
Related Topics: In Vitro Diagnostics